A worldwide coalition of researchers and clinicians has agreed that light therapy is among the most effective interventions for the prevention of oral mucositis, painful ulcers in the mouth resulting from cancer therapy.

New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted therapy.

A layer of cells that look like normal stomach lining on top of sites of stomach cancer can make it difficult to spot after removal of a Helicobacter pylori infection.

The biliary microbiome – the collection of bacteria present in the bile ducts – was altered in patients who received neoadjuvant therapy prior to undergoing surgery for pancreatic cancer.

A study led by researchers at RCSI’s Department of Chemistry has the potential to help surgeons more accurately remove tumours and detect cancer in lymph nodes during surgery.

Researchers have identified a new drug combination that is effective against metastatic uveal melanoma cells in preclinical studies.

Researchers have discovered a way to improve immune-based treatments, such as adoptive T-cell therapy (ACT) and haematopoietic stem cell transplantation (HSCT), by modulating T-cells with thioredoxin, a powerful, naturally occurring antioxidant molecule.

The Researchers from HSE University (The Higher School of Economics) have used machine learning to discover that the two most widespread DNA structures – stem-loops and quadruplexes – cause genome mutations that lead to cancer.